Anna Hemnes

Dr Anna Hemnes is a translational physician-scientist researching altered metabolism in pulmonary vascular disease. Her research focuses on the effect of BMPR2 mutation on insulin-mediated intracellular signalling in the pulmonary vasculature and right ventricle, and the genetic susceptibility to insulin resistance and metabolic syndrome in human pulmonary vascular disease. 

Her work has led to the development of an Omic signature of vasodilator-responsive pulmonary arterial hypertension, and she is actively researching novel blood-based Omic predictive strategies for FDA-approved therapies for pulmonary arterial hypertension. Dr Hemnes sees patients at the Vanderbilt Center for Pulmonary Vascular Disease and serves as the Director of Research for the Division of Allergy, Pulmonary and Critical Care Medicine at Vanderbilt University Medical Center.